Please assess the completion status of the following clinical trial:

Trial Title: To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy adult males between 21 and 60 years of age who have been diagnosed with AIHH.~* Subjects must have been treated with a topical testosterone replacement therapy (typically AndroGel® or Testim®) for at least 6 months at enrollment and for not more than 2 years.~Exclusion Criteria:~* A history of idiopathic infertility due to primary hypogonadism, testicular failure, Kallmann's syndrome or any other infertility condition.~* Subjects demonstrating any clinically significant medical condition rendering the subjects infertile or marginally fertile other than AIHH.~* Men with a history of, known, or suspected prostate disease not ruled out by a prostate biopsy, or a prostate specific antigen (PSA)\>3.6 or clinical suspicion of current prostate disease.~* Men with a hematocrit in excess of 50 % or hemoglobin \>17 g/dl

- Gender: MALE
- Minimum Age: 21 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- 25 mg Androxal no wash out (Type: EXPERIMENTAL): 1 capsule daily for 6 months of 25 mg of Androxal in men without a 3 month wash out period
- Testim 1% (topical testosterone) (Type: ACTIVE_COMPARATOR): Testim 1% Gel applied topically for 6 months
- 25 mg Androxal wash out (Type: EXPERIMENTAL): 1 x 25 mg Androxal capsule daily for 6 months in men with a previous 3 month washout period of topical testosterone

Based on this trial design, predict the completion outcome and termination type (if applicable).